Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonneoplastic hematologic disease.

E C Tozman1

  • 1University of Miami School of Medicine, Florida.

Current Opinion in Rheumatology
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Erythropoietin effectively treats anemia in rheumatoid arthritis patients without adverse effects. However, it does not improve the underlying rheumatic disease or patient function, warranting further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations.

Seminars in arthritis and rheumatism·1995
Same author

Hematologic disorders in rheumatic diseases.

Current opinion in rheumatology·1994
Same author

Sickle-cell disease, hemophilia, and hematology.

Current opinion in rheumatology·1993
Same author

Sarcoidosis: clinical manifestations, epidemiology, therapy, and pathophysiology.

Current opinion in rheumatology·1991
Same author

Sarcoidosis.

Current opinion in rheumatology·1989
Same author

Adverse reactions with oral and parenteral gold preparations.

Medical toxicology·1987
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Hematology
  • Rheumatology
  • Internal Medicine

Background:

  • Anemia is a common complication in rheumatic disorders.
  • Anemia of chronic disease, including rheumatoid arthritis, presents unique challenges.
  • Erythropoietin has shown efficacy in treating anemia associated with other chronic conditions.

Purpose of the Study:

  • To review current concepts on anemia in rheumatic disorders.
  • To evaluate the efficacy and safety of erythropoietin in alleviating anemia of rheumatoid arthritis.
  • To explore potential future therapeutic avenues for anemia in rheumatic diseases.

Main Methods:

  • Literature review of nonneoplastic hematologic diseases in rheumatic disorders.
  • Analysis of studies investigating erythropoietin administration (intravenous or subcutaneous) in rheumatoid arthritis patients.

Related Experiment Videos

  • Examination of data on treatment outcomes, including hematologic parameters, disease activity, and functional abilities.

    • Main Results:

    • Erythropoietin administration effectively alleviated anemia in rheumatoid arthritis patients.
    • Treatment with erythropoietin showed no apparent adverse reactions.
    • No significant improvement was observed in the underlying rheumatoid disease activity or functional status of the patients.

    Conclusions:

    • Erythropoietin therapy can successfully manage anemia in rheumatoid arthritis.
    • Further investigation is required to establish the definitive role of erythropoietin in rheumatoid arthritis and other rheumatic diseases.
    • Understanding underlying mechanisms of anemia may lead to novel therapeutic strategies.